Post-approval studies (Phase 4)Study completedNCT01948791
What this trial is testing
16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients
Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 222